This study is looking at how well and how safely a product called NeoThelium FT works for people with chronic pressure ulcers (bedsores). NeoThelium FT is a special wound covering made from donated human placental tissue. You might be able to join if you are 18 or older and have a Stage 2 or 3 pressure ulcer on your pelvis or lower leg that is between 1 and 30 square centimeters in size and not infected. The main goal is to see if your wound completely closes within 1 to 16 weeks. This study is currently unclear on its recruitment status and plans to enroll 10 participants.

Study design

This is an open-label study, meaning both you and the researchers will know you are receiving NeoThelium FT. It is a case series, and about 10 people are expected to participate.

What's involved

If you join, you will receive weekly applications of NeoThelium FT in addition to standard care. You will continue with follow-up visits according to the study schedule.

Compensation

Not stated in the trial record.

Follow-up

The study measures complete wound closure between 1 and 16 weeks, indicating follow-up during this period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.